Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.50

  • SJR 0.263

  • Impact Factor 0.4 (2024)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus
Submit

Indian Journal of Animal Research, volume 34 issue 2 (july to december 2000) : 95-99

PHARMACOKINETICS ~D DISTRIBUTION OF PEFLOXACIN IN BIOLOGICAL FLUIDS OF LACTATING GOATS AFTER INTRAVENOUS ADMINISTRATION

M.K. Ansari, S.P. Sinha, C. Jayachandran, M.K. Singh
1Department of Pharmacology & Toxicology, Bihar Veterinary College, Patna-800 014, India

  • Submitted|

  • First Online |

  • doi

Cite article:- Ansari M.K., Sinha S.P., Jayachandran C., Singh M.K. (2024). PHARMACOKINETICS ~D DISTRIBUTION OF PEFLOXACIN IN BIOLOGICAL FLUIDS OF LACTATING GOATS AFTER INTRAVENOUS ADMINISTRATION. Indian Journal of Animal Research. 34(2): 95-99. doi: .

ABSTRACT

Pharmacokinetic study of pefloxacin (4 mg/kg i.v.) in goats revealed peak concentrations of 9.06±1.30, 4.29±0.32 and 46.45±2.16 μg/ml were attained at 5,45 and 45 min in plasma, milk and urine. The therapeutic concentration (≥0.12 μg/ml) was maintained upto 8, 8 and 30 hr in plasma, milk and urine. The mean distribution half life (t½α), elimination half life (t½β) and total body clearance (Cl8) of 0.27±0.06 hr, 3.53±2.26 hr and 5.07±1.15 ml.kg−1 min−1 were estimated. A high Vd area of 1.59±0.42 L/kg and tissue to plasma concentration ratio (T∼P) of 1.46±0.26 indicate that the drug is well distributed

KEYWORDS

    REFERENCES

    1. Baggot, J.D. (1977). Principles of drug disposition in domestic animals. The basis of Veterinary Clinical Pharmacology, 1st Edn. W.B. Saunders Company, Philadelphia.
    2. Barre, J.,G. and Tillment, J.P. (1984). J. Parmac. Sci. 73 : 1379-1382.
    3. Cardey, J. et al. (1987). Eur. J. Clin. Pharmacol. 33 : 469-472.
    4. Chousalkar, M.S. (1995). M.V.Sc. Thesis, Konkan Krishi Vidyapeeth, Dapoli, India.
    5. Cocherearu, M.L. et al, (1991). Antimicrob. Agents Chemother. 35 : 1112-1115.
    6. Danan, G. et a/. (1985). Pharmacol. Ther. 38 : 439-442.
    7. Dworkin, R. et al. (1990). Antimicrob Agents Chemother 34 : 1016-1044
    8. Frydman, A.M: et al. (1986). J. Antimicrob. Chemother. 17 (supp!. B.) : 65-79.
    9. Vol. 34, No.2, 2000 99
    10. Gibaldi, M. and Perrier, D. (1975). Pharmacokinetics, Marcel Dekkar Inc. New York.
    11. Hoffler, D. et al. (1988). Arzncimittel Forschung. 38 : 739-743.
    12. Jare, N.M. (1996). M.V.Sc. Thesis, Konkan Krlshl Vidyapeeth, Dapoli, Maharashtra, India.
    13. Jayakumar, K. et al. (1995). In 2nd NCVPT conference and National Symposium on "Quality
    14. Drugs for Assured Productivity in animal". Mumbai, India, Dec., 22, 1995.
    15. Montay, G. et al. (1984). Antimicrob. Agents Chemother. 25 : 463-472.
    16. Notari, R. E. (1980). Biopharmaceutics and clinical pharmacokinetics. 3rd edn. Marcel Dekkar Inc. New York.
    17. PatH, R.V. (1994). M.V.Sc. Thesis, Konkan Vidyapeeth, Dapoli, India.
    18. Sharma, A.K. et al. (1994). Indian J. Pharmacol. 26 : 249-261.
    19. Sultan, E. et al. (1988). Eur. J. Clin. Pharmacol. 34 : 637-643.
    20. Wolfson, J.S. and Hopper, D.C. (1991). Eur. J. of Clin. Microb. InF. Dis. 10 267-274.
    Reviewed By

    Download Article
    In this Article
      Contact us
      Follow us

      Editorial Board

      View all (0)